This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Identify which states tax mining income in 2026 and grasp the key tax implications for miners. This primer covers rules you should know and steps to stay compliant.
26,499 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A rural Georgia appliance plant combats a severe labor shortage by letting workers choose shifts through an app, easi...
A rising capital markets wave is lifting expectations for banks, with a forecast of about 25% earnings growth for the...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Oil prices surged into the high $70s as traffic through the Strait of Hormuz halted, stoking fears of tighter supply....
Specialized Medicare Advantage plans targeting chronic conditions and low-income subscribers accounted for the majori...
CoreWeave surged after its IPO, then pulled back dramatically. This guide explains what happened, what the company do...
Markets react to a high-stakes claim about Iran policy as four living ex-presidents deny involvement. Oil climbs, sto...
Oil markets jump as tensions with Iran intensify. The IEA warns the iran crisis worst energy shock may strain economi...
The Iran-backed Houthis say they fired on Israel, marking their first missile strike in the current conflict. Israel ...
April's CPI rose 3.8% year over year, signaling ongoing cost pressure for households. This report captures how famili...